1. Scrip
  2. >>Business
  3. >>Strategy

Apple, Google’s Cookie-Less World To Social Media, What Is Pharma's Digital Marketing Strategy?

'Fish Where The Fish Are'

 
• By Vibha Ravi

Heads of digital at Janssen and Gilead, along with Evermed’s CEO, share insights to address a cookie-less environment created by Apple and Google, ensure accuracy of social media content and drive HCP engagement via digital strategy during a panel discussion on omnichannel marketing.

Omnichannel Marketing
New Technologies, Channels Require Omnichannel Marketing To Be Nimble • Source: Shutterstock

Omnichannel marketing integrates multiple channels to deliver a unified and consistent brand experience to the customer. While the concept is simple enough, implementation is anything but, and changing technology and channels only add to its complexity, pharma executives revealed at a recent summit.

Head of Digital Strategy, EMEA for the Janssen Pharmaceutical Companies of Johnson & Johnson, Adam Higgins, global head of Digital and Innovation at Gilead Sciences, Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

End Is Nigh For 4SC After EMA’s No For Kinselby

 
• By Kevin Grogan

The German biotech has discontinued the oral HDAC inhibitor for cutaneous T-cell lymphoma.

HHS Intensifies Pressure On Pharma With MFN Pricing Benchmark

 
• By Jessica Merrill

The Trump administration released more details on “most favored nation” price targets drug companies are expected to apply to US drug prices.

Affimed’s ASCO ‘Hail Mary’ As Survival Chances Slim

 
• By Kevin Grogan

The German biotech has been forced into insolvency and NASDAQ suspension.

Mission Vision: How Roche Hopes To Impact Eye Health Outcomes In APAC

 
• By Anju Ghangurde

Roche Pharmaceuticals’ area head, Asia Pacific, outlines how the Swiss group is helping nurture the wider ecosystem and setting itself up for a bigger play in the ophthalmology space by combining scientific expertise with regional insights.

More from Business

Pfizer Scoops 3SBio’s PD-1/VEGF Bispecific In ADC Combo Push

 
• By Dexter Jie Yan

Pfizer is doubling down on partnerships for combination therapies involving its antibody-drug conjugates through a new alliance with China's 3SBio’s for a bispecific antibody, potentially worth up to $6bn.

CRISPR Thinks Outside Gene-Editing Box With Sirius Deal

 
• By Alaric DeArment

The gene-editing company is making a deal with RNA interference-focused Sirius, but still focusing on cardiovascular disease, a major area of its pipeline.

HHS Intensifies Pressure On Pharma With MFN Pricing Benchmark

 
• By Jessica Merrill

The Trump administration released more details on “most favored nation” price targets drug companies are expected to apply to US drug prices.